PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2013

Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways.

Rat / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 23446291 ↗2013Reported benefit

Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways.

RatChemical/toxinSprague-DawleyMale

Model: Contrast-induced nephropathy (acute kidney injury) induced by contrast medium

Tetramethylpyrazine significantly attenuated the renal dysfunction and renal tubular cell apoptosis caused by contrast medium. Mechanistically it decreased phospho-p38 MAPK, attenuated the rise in FoxO1 mRNA and nuclear protein, inhibited inducible nitric oxide synthase and Bax, and upregulated Bcl…

Extraction: extract · Supplied extraction confidence: 0.65. Machine-extracted fields require source verification.